Avidian Wealth Enterprises’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$9.65M Buy
38,004
+79
+0.2% +$18.4K 0.27% 66
2026
Q1
$9.27M Buy
37,925
+17,531
+86% +$4.08M 0.29% 58
2025
Q4
$4.22M Buy
20,394
+573
+3% +$113K 0.15% 89
2025
Q3
$3.68M Buy
19,821
+1,232
+7% +$211K 0.14% 94
2025
Q2
$2.84M Sell
18,589
-201
-1% -$30.9K 0.12% 97
2025
Q1
$3.12M Buy
18,790
+1,698
+10% +$266K 0.14% 91
2024
Q4
$2.47M Buy
17,092
+343
+2% +$53.2K 0.11% 106
2024
Q3
$2.71M Buy
16,749
+452
+3% +$72K 0.12% 95
2024
Q2
$2.38M Sell
16,297
-861
-5% -$128K 0.1% 105
2024
Q1
$2.71M Buy
17,158
+1,479
+9% +$235K 0.13% 89
2023
Q4
$2.46M Sell
15,679
-1,822
-10% -$279K 0.15% 93
2023
Q3
$2.73M Sell
17,501
-3,174
-15% -$524K 0.19% 85
2023
Q2
$3.42M Sell
20,675
-12,327
-37% -$1.99M 0.22% 83
2023
Q1
$5.12M Buy
33,002
+1,071
+3% +$173K 0.28% 70
2022
Q4
$5.64M Buy
31,931
+8,536
+36% +$1.47M 0.37% 58
2022
Q3
$3.82M Buy
23,395
+1,603
+7% +$271K 0.28% 67
2022
Q2
$3.87M Buy
21,792
+2,958
+16% +$527K 0.27% 71
2022
Q1
$3.34M Buy
18,834
+132
+0.7% +$22.5K 0.2% 88
2021
Q4
$3.2M Buy
18,702
+4,207
+29% +$689K 0.2% 89
2021
Q3
$2.34M Buy
14,495
+926
+7% +$158K 0.18% 88
2021
Q2
$2.23M Buy
13,569
+272
+2% +$45K 0.17% 91
2021
Q1
$2.19M Sell
13,297
-342
-3% -$55.3K 0.19% 82
2020
Q4
$2.15M Buy
13,639
+343
+3% +$50.6K 0.2% 74
2020
Q3
$1.98M Buy
13,296
+277
+2% +$41K 0.22% 70
2020
Q2
$1.83M Buy
13,019
+574
+5% +$83.6K 0.25% 62
2020
Q1
$1.63M Buy
12,445
+1,194
+11% +$169K 0.26% 47
2019
Q4
$1.64M Buy
11,251
+412
+4% +$55.9K 0.23% 46
2019
Q3
$1.4M Buy
10,839
+16
+0.1% +$2.11K 0.23% 42
2019
Q2
$1.51M Buy
10,823
+7,648
+241% +$1.06M 0.36% 27
2019
Q1
$444K Buy
3,175
+145
+5% +$19.4K 0.1% 76
2018
Q4
$391K Buy
3,030
+247
+9% +$34.5K 0.14% 50
2018
Q3
$384K Buy
2,783
+318
+13% +$42.3K 0.12% 70
2018
Q2
$299K Sell
2,465
-190
-7% -$23.7K 0.09% 73
2018
Q1
$340K Sell
2,655
-31
-1% -$4.19K 0.11% 65
2017
Q4
$375 Buy
2,686
+882
+49% +$123K 0.1% 65
2017
Q3
$235K Buy
+1,804
New +$239K 0.09% 75
2016
Q4
Sell
-1,915
Closed -$226K 89
2016
Q3
$226K Sell
1,915
-46
-2% -$5.58K 0.09% 67
2016
Q2
$238 Sell
1,961
-355
-15% -$40.3K 0.09% 61
2016
Q1
$251K Sell
2,316
-367
-14% -$38K 0.13% 53
2015
Q4
$276K Buy
+2,683
New +$270K 0.13% 30
2015
Q2
Sell
-2,076
Closed -$209K 42
2015
Q1
$209K Buy
2,076
+102
+5% +$10.4K 0.09% 35
2014
Q4
$206K Sell
1,974
-52
-3% -$5.48K 0.08% 33
2014
Q3
$216K Sell
2,026
-108
-5% -$11.2K 0.08% 38
2014
Q2
$223K Buy
+2,134
New +$216K 0.08% 42

Other funds holding JNJ

Avidian Wealth Enterprises's JNJ Position: Q2 2026 in Review

Avidian Wealth Enterprises increased its Johnson & Johnson (JNJ) stake by 0.21% in Q2 2026, buying an estimated $18.4K and bringing the position to 38,004 shares worth $9.65M. The position accounts for 0.27% of the portfolio, ranked #66.

Avidian Wealth Enterprises first reported a position in JNJ in Q2 2014 and has held it in 44 quarters since. 4,656 funds tracked by Wall St. Rank hold JNJ as of Q2 2026.

  • Avidian Wealth Enterprises held 38,004 shares of Johnson & Johnson worth $9.65M as of Q2 2026.
  • Avidian Wealth Enterprises bought 79 Johnson & Johnson shares in Q2 2026, an estimated $18.4K.
  • Johnson & Johnson made up 0.27% of Avidian Wealth Enterprises's portfolio in Q2 2026, its #66 holding.
  • Avidian Wealth Enterprises first reported a position in Johnson & Johnson in Q2 2014 and has held it in 44 quarters since.
  • 4,656 funds tracked by Wall St. Rank held Johnson & Johnson as of Q2 2026.

Based on Avidian Wealth Enterprises's 13F filing for Q2 2026, filed 24 Jul 2026.